Logo-jre
Submitted: 16 Feb 2023
Accepted: 17 Apr 2023
ePublished: 25 Apr 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2023;9: 25084.
doi: 10.34172/jre.2023.25084
  Abstract View: 35
  PDF Download: 27

Epidemiology and Prevention

Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends

Hamid Nasri 1 ORCID logo, Sepideh Ghanbari-nejad 1 ORCID logo, Mina Dehghani 1 ORCID logo, Anastasia Dieti 2* ORCID logo

1 Nickan Research Institute, Isfahan, Iran.
2 Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 2404, Cyprus.
*Corresponding Author: Corresponding Author: Anastasia Dieti, Email: a.dieti@external.euc.ac.cy, , Email: anastasiadieti@yahoo.co.uk

Citation: Nasri H, Ghanbari-nejad S, Dehghani M, Dieti A. Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends. J Ren Endocrinol. 2023;9:e25084. doi: 10.34172/jre.2023.25084.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 36

Your browser does not support the canvas element.


PDF Download: 27

Your browser does not support the canvas element.